questionsmedicales.fr
Composés chimiques organiques
Composés du soufre
Sulfones
Sulfonamides
Bumétanide
Bumétanide : Questions médicales fréquentes
Diagnostic
5
Insuffisance cardiaque
Échocardiographie
Rétention d'eau
Poids corporel
Fonction rénale
Créatinine
Essoufflement
Douleur thoracique
Symptômes
5
Effets secondaires
Déséquilibre électrolytique
Hypertension
Maux de tête
Réaction allergique
Éruption cutanée
Prévention
5
Effets secondaires
Électrolytes
Traitements
5
Administration de médicaments
Voie intraveineuse
Interactions médicamenteuses
Antihypertenseurs
Surveillance médicale
Pression artérielle
Diurétiques
Modifications du mode de vie
Complications
5
Hypokaliémie
Déshydratation
Insuffisance rénale
Diurétiques
Surveillance
Électrolytes
Réaction médicamenteuse
Éruption cutanée
Effets à long terme
Déséquilibres électrolytiques
Facteurs de risque
5
Antécédents médicaux
Maladies rénales
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bumétanide : Questions médicales les plus fréquentes",
"headline": "Bumétanide : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bumétanide : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-17",
"dateModified": "2026-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bumétanide"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sulfonamides",
"url": "https://questionsmedicales.fr/mesh/D013449",
"about": {
"@type": "MedicalCondition",
"name": "Sulfonamides",
"code": {
"@type": "MedicalCode",
"code": "D013449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Bumétanide",
"alternateName": "Bumetanide",
"code": {
"@type": "MedicalCode",
"code": "D002034",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wolfgang Löscher",
"url": "https://questionsmedicales.fr/author/Wolfgang%20L%C3%B6scher",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine Hannover, Hannover, Germany."
}
},
{
"@type": "Person",
"name": "Hilgo Bruining",
"url": "https://questionsmedicales.fr/author/Hilgo%20Bruining",
"affiliation": {
"@type": "Organization",
"name": "N=You Neurodevelopmental Precision Center, Amsterdam Neuroscience, Amsterdam Reproduction and Development, Amsterdam UMC, Meibergdreef 5, 1105, AZ, Amsterdam, The Netherlands. h.bruining@amsterdamumc.nl."
}
},
{
"@type": "Person",
"name": "Dorinde M van Andel",
"url": "https://questionsmedicales.fr/author/Dorinde%20M%20van%20Andel",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands. D.m.vanandel@umcutrecht.nl."
}
},
{
"@type": "Person",
"name": "Jan J Sprengers",
"url": "https://questionsmedicales.fr/author/Jan%20J%20Sprengers",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands."
}
},
{
"@type": "Person",
"name": "Kerstin Römermann",
"url": "https://questionsmedicales.fr/author/Kerstin%20R%C3%B6mermann",
"affiliation": {
"@type": "Organization",
"name": "Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine Hannover, Hannover, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.",
"datePublished": "2023-10-04",
"url": "https://questionsmedicales.fr/article/37794745",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/aur.3005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets.",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37364772",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xphs.2023.06.013"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease.",
"datePublished": "2023-08-04",
"url": "https://questionsmedicales.fr/article/37601062",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fphar.2023.1190402"
}
},
{
"@type": "ScholarlyArticle",
"name": "Heterogeneous brain distribution of bumetanide following systemic administration in rats.",
"datePublished": "2024-06-01",
"url": "https://questionsmedicales.fr/article/38823029",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/bdd.2390"
}
},
{
"@type": "ScholarlyArticle",
"name": "Technical Comment on \"Inhibition mechanism of NKCC1 involves the carboxyl terminus and long-range conformational coupling\".",
"datePublished": "2023-07-12",
"url": "https://questionsmedicales.fr/article/37436990",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/sciadv.adh0821"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du soufre",
"item": "https://questionsmedicales.fr/mesh/D013457"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sulfones",
"item": "https://questionsmedicales.fr/mesh/D013450"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sulfonamides",
"item": "https://questionsmedicales.fr/mesh/D013449"
},
{
"@type": "ListItem",
"position": 6,
"name": "Bumétanide",
"item": "https://questionsmedicales.fr/mesh/D002034"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bumétanide - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bumétanide",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bumétanide",
"description": "Comment diagnostiquer une insuffisance cardiaque ?\nQuels tests pour évaluer l'œdème ?\nQuels signes indiquent une rétention d'eau ?\nComment évaluer la fonction rénale ?\nQuels symptômes nécessitent un diagnostic urgent ?",
"url": "https://questionsmedicales.fr/mesh/D002034#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bumétanide",
"description": "Quels sont les effets secondaires du bumétanide ?\nComment reconnaître une déshydratation ?\nQuels symptômes d'hypertension sont fréquents ?\nQuels signes d'œdème doivent alerter ?\nQuels symptômes indiquent une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D002034#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bumétanide",
"description": "Comment prévenir l'hypertension ?\nQuels conseils pour éviter l'œdème ?\nComment éviter les effets secondaires du bumétanide ?\nQuelles habitudes alimentaires sont recommandées ?\nComment gérer le stress pour la santé cardiaque ?",
"url": "https://questionsmedicales.fr/mesh/D002034#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bumétanide",
"description": "Comment le bumétanide est-il administré ?\nQuels médicaments interagissent avec le bumétanide ?\nQuelle est la posologie habituelle du bumétanide ?\nComment surveiller l'efficacité du traitement ?\nQuels sont les traitements alternatifs à considérer ?",
"url": "https://questionsmedicales.fr/mesh/D002034#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bumétanide",
"description": "Quelles complications peuvent survenir avec le bumétanide ?\nQuels risques d'insuffisance rénale ?\nComment prévenir les complications liées au traitement ?\nQuels signes d'une réaction sévère au médicament ?\nQuels effets à long terme du bumétanide ?",
"url": "https://questionsmedicales.fr/mesh/D002034#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bumétanide",
"description": "Quels facteurs augmentent le risque d'hypertension ?\nComment l'âge influence-t-il le risque cardiaque ?\nQuels antécédents médicaux sont préoccupants ?\nQuel rôle joue le mode de vie dans le risque d'œdème ?\nComment le stress affecte-t-il la santé ?",
"url": "https://questionsmedicales.fr/mesh/D002034#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une insuffisance cardiaque ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen clinique, des tests sanguins et une échographie cardiaque sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'œdème ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen physique et des tests d'imagerie comme l'échographie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une rétention d'eau ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gain de poids rapide, un gonflement des jambes et des pieds sont des signes clés."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction rénale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour la créatinine et l'urée, ainsi qu'une analyse d'urine sont effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic urgent ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Essoufflement sévère, douleur thoracique ou confusion mentale doivent être évalués rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires du bumétanide ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets incluent des déséquilibres électrolytiques, des vertiges et des maux de tête."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une déshydratation ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent soif intense, sécheresse de la bouche et urine foncée."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'hypertension sont fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maux de tête, les saignements de nez et les vertiges peuvent indiquer une hypertension."
}
},
{
"@type": "Question",
"name": "Quels signes d'œdème doivent alerter ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement soudain des jambes ou du visage nécessite une évaluation médicale."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une réaction allergique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruption cutanée, démangeaisons et difficulté à respirer peuvent signaler une allergie."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypertension ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et la gestion du stress sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels conseils pour éviter l'œdème ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Élever les jambes, réduire le sel et rester actif peuvent aider à prévenir l'œdème."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets secondaires du bumétanide ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les recommandations médicales et surveiller les niveaux d'électrolytes est crucial."
}
},
{
"@type": "Question",
"name": "Quelles habitudes alimentaires sont recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en potassium et faible en sodium est conseillée pour les patients."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour la santé cardiaque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation comme le yoga et la méditation peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Comment le bumétanide est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est généralement administré par voie orale ou intraveineuse selon la condition."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec le bumétanide ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anti-inflammatoires non stéroïdiens et certains antihypertenseurs peuvent interagir."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie habituelle du bumétanide ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie, mais commence souvent à 0,5 à 2 mg par jour selon la condition."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des contrôles réguliers de la pression artérielle et des tests de laboratoire sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements alternatifs à considérer ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres diurétiques ou des modifications du mode de vie peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le bumétanide ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'hypokaliémie et la déshydratation peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques d'insuffisance rénale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation excessive peut entraîner une insuffisance rénale aiguë chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées au traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller régulièrement les électrolytes et ajuster la posologie aide à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels signes d'une réaction sévère au médicament ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des éruptions cutanées sévères ou un gonflement du visage doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme du bumétanide ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation prolongée peut entraîner des déséquilibres électrolytiques et des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'hypertension ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme et une alimentation riche en sodium sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque cardiaque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de maladies cardiaques augmente avec l'âge en raison de divers facteurs physiologiques."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont préoccupants ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents d'hypertension ou de maladies rénales augmentent le risque de complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans le risque d'œdème ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sédentaire et une mauvaise alimentation peuvent accroître le risque d'œdème."
}
},
{
"@type": "Question",
"name": "Comment le stress affecte-t-il la santé ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut contribuer à l'hypertension et à d'autres problèmes de santé."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/03/2026
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine Hannover, Hannover, Germany.
Center for Systems Neuroscience Hannover, Hannover, Germany.
7 publications dans cette catégorie
Affiliations :
N=You Neurodevelopmental Precision Center, Amsterdam Neuroscience, Amsterdam Reproduction and Development, Amsterdam UMC, Meibergdreef 5, 1105, AZ, Amsterdam, The Netherlands. h.bruining@amsterdamumc.nl.
Child and Adolescent Psychiatry and Psychosocial Care, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1105, 1081, HV, Amsterdam, the Netherlands. h.bruining@amsterdamumc.nl.
Levvel, Center for Child and Adolescent Psychiatry, Meibergdreef 5, 1105, AZ, Amsterdam, The Netherlands. h.bruining@amsterdamumc.nl.
6 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands. D.m.vanandel@umcutrecht.nl.
6 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
5 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine Hannover, Hannover, Germany.
Publications dans "Bumétanide" :
5 publications dans cette catégorie
Affiliations :
Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Bumétanide" :
5 publications dans cette catégorie
Affiliations :
Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Bumétanide" :
5 publications dans cette catégorie
Affiliations :
Department of Developmental and Behavioral Pediatric & Child Primary Care, Brain and Behavioural Research Unit of Shanghai Institute for Pediatric Research and Ministry of Education-Shanghai Key Laboratory for Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Neurochlore, Fundamental Research Department, Ben-Ari Institute of Neuroarcheology, Marseille, France.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
BA Therapeutics and Neurochlore, Campus Scientifique de Luminy, Marseille, France.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine, Hannover, Germany.
Center for Systems Neuroscience, Hannover, Germany.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Developmental and Behavioural Pediatric & Child Primary Care, Brain and Behavioural Research Unit of Shanghai Institute for Pediatric Research and MOE-Shanghai Key Laboratory for Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Developmental and Behavioural Pediatric & Child Primary Care, Brain and Behavioural Research Unit of Shanghai Institute for Pediatric Research and MOE-Shanghai Key Laboratory for Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Center for Experimental Studies and Research, The First Affiliated Hospital of Kunming Medical University, 650032, Kunming, China.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Developmental and Behavioural Pediatric & Child Primary Care, Brain and Behavioural Research Unit of Shanghai Institute for Pediatric Research and MOE-Shanghai Key Laboratory for Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
Department of Developmental and Behavioural Pediatric & Child Primary Care, Brain and Behavioural Research Unit of Shanghai Institute for Pediatric Research and MOE-Shanghai Key Laboratory for Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Department of Psychiatry and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, CB21TN, UK.
National Clinical Research Center for Aging and Medicine at Huashan Hospital, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science and Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, 200433, Shanghai, China.
Publications dans "Bumétanide" :
4 publications dans cette catégorie
Affiliations :
National Clinical Research Center for Aging and Medicine at Huashan Hospital, State Key Laboratory of Medical Neurobiology and Ministry of Education Frontiers Center for Brain Science, Institutes of Brain Science and Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, 200433, Shanghai, China. qluo@fudan.edu.cn.
Human Phenome Institute, Fudan University, 201203, Shanghai, China. qluo@fudan.edu.cn.
Center for Computational Psychiatry, Ministry of Education-Key Laboratory of Computational Neuroscience and Brain-Inspired, Research Institute of Intelligent Complex Systems, Fudan University, 200040, Shanghai, China. qluo@fudan.edu.cn.
Publications dans "Bumétanide" :
3 publications dans cette catégorie
Affiliations :
Molecular and Integrative Biosciences and Neuroscience Center, University of Helsinki, Helsinki, Finland.
Publications dans "Bumétanide" :
3 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Toxicology, and Pharmacy, University of Veterinary Medicine Hannover, Hannover, Germany.
Publications dans "Bumétanide" :
The efficacy and safety of bumetanide oral solution for the treatment of autism spectrum disorder (ASD) in children and adolescents was evaluated in two international, multi-center, randomized, double...
Nitrosamine compounds are classified as potential human carcinogens, the origin of these impurities can be broadly classified in two categories, nitrosamine impurity found in drug products that are no...
Therapeutics discovery and development for Alzheimer's disease (AD) has been an area of intense research to alleviate memory loss and the underlying pathogenic processes. Recent drug discovery approac...
Bumetanide is used widely as a tool and off-label treatment to inhibit the Na-K-2Cl cotransporter NKCC1 in the brain and thereby to normalize intra-neuronal chloride levels in several brain disorders....
Flygaard, Habeck and Nissen question claims on bumetanide and furosemide binding to sodium-potassium-chloride cotransporter NKCC1....
Omadacycline is a broad-spectrum intravenous and oral tetracycline antibiotic approved for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection...
Omadacycline was prepared at concentrations consistent with a maintenance dose (1 mg/mL) and a loading dose (2 mg/mL) with 0.9% sodium chloride according to the prescribing information. Compatibility ...
Omadacycline appeared physically compatible with lactated Ringer's solution, magnesium sulfate, normal saline with potassium chloride, bumetanide, heparin, and insulin at standard infusion concentrati...
Omadacycline appeared physically compatible with all products tested and incompatible with furosemide. Simultaneous administration of omadacycline with tested intravenous medications, except furosemid...
Acting on the main target of dopaminergic cells, the striatal γ-aminobutyric acid (GABA)-ergic cells, might be a new way to treat persons with Parkinson's disease (PD)....
The objective of this study was to assess the efficacy of bumetanide, an Na-K-Cl cotransporter (NKCC1) inhibitor, to improve motor symptoms in PD....
This was a 4-month double-blind, randomized, parallel-group, placebo-controlled trial of 1.75 to 3 mg/day bumetanide as an adjunct to levodopa in 44 participants with PD and motor fluctuations....
Compared to the baseline, the mean change in OFF Movement Disorder Society Unified Parkinson's Disease Rating Scale Part III score after 4 months of treatment (primary endpoint) did not improve signif...
There was no evidence in this study that bumetanide has efficacy in improving motor symptoms of PD. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International...
Bumetanide, a loop diuretic, was identified as a candidate drug for repurposing for Alzheimer's disease (AD) based on its effects on transcriptomic apolipoprotein E signatures. Cross-sectional analyse...
We evaluated Medicare claims data using Cox proportional hazards regression to evaluate the association between time-dependent use of bumetanide and time to first AD diagnosis while controlling for pa...
We sampled 833,561 Medicare beneficiaries, 60.8% female, with mean (standard deviation) age of 70.4 (12). Bumetanide use was not significantly associated with AD risk (hazard ratio 1.05; 95% confidenc...
Using a nationwide dataset and a retrospective cohort study design, we were not able to identify a time-dependent effect of bumetanide lowering AD risk....
Bumetanide was identified as a candidate for repurposing for Alzheimer's disease (AD). We evaluated the association between bumetanide use and risk of AD. We used Medicare data and accounted for durat...
This meta-analysis aimed to describe the efficacy of bumetanide in improving infarct volume, brain edema, and behavioral outcomes in animal models of cerebral ischemia. Embase, PubMed and Web of Scien...